These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1301071)

  • 1. Reductive metabolism of diaziquone (AZQ) in the S9 fraction of MCF-7 cells. II. Enhancement of the alkylating activity of AZQ by NAD(P)H: quinone-acceptor oxidoreductase (DT-diaphorase).
    Fisher GR; Donis J; Gutierrez PL
    Biochem Pharmacol; 1992 Oct; 44(8):1625-35. PubMed ID: 1301071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The reductive metabolism of diaziquone (AZQ) in the S9 fraction of MCF-7 cells: free radical formation and NAD(P)H: quinone-acceptor oxidoreductase (DT-diaphorase) activity.
    Fisher GR; Gutierrez PL
    Free Radic Biol Med; 1991; 10(6):359-70. PubMed ID: 1654286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Free radical formation and DNA strand breakage during metabolism of diaziquone by NAD(P)H quinone-acceptor oxidoreductase (DT-diaphorase) and NADPH cytochrome c reductase.
    Fisher GR; Gutierrez PL
    Free Radic Biol Med; 1991; 11(6):597-607. PubMed ID: 1663902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of diaziquone by NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase): role in diaziquone-induced DNA damage and cytotoxicity in human colon carcinoma cells.
    Siegel D; Gibson NW; Preusch PC; Ross D
    Cancer Res; 1990 Nov; 50(22):7293-300. PubMed ID: 2121335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiol oxidation coupled to DT-diaphorase-catalysed reduction of diaziquone. Reductive and oxidative pathways of diaziquone semiquinone modulated by glutathione and superoxide dismutase.
    Ordoñez ID; Cadenas E
    Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):481-90. PubMed ID: 1530580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation and deactivation of quinones catalyzed by DT-diaphorase. Evidence for bioreductive activation of diaziquone (AZQ) in human tumor cells and detoxification of benzene metabolites in bone marrow stroma.
    Ross D; Siegel D; Gibson NW; Pacheco D; Thomas DJ; Reasor M; Wierda D
    Free Radic Res Commun; 1990; 8(4-6):373-81. PubMed ID: 2113030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reductive activation of diaziquone and possible involvement of free radicals and the hydroquinone dianion.
    Gutierrez PL; Biswal S; Nardino R; Biswal N
    Cancer Res; 1986 Nov; 46(11):5779-85. PubMed ID: 3019536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of NAD(P)H:quinone oxidoreductase in quinone-mediated p21 induction in human colon carcinoma cells.
    Qiu XB; Cadenas E
    Arch Biochem Biophys; 1997 Oct; 346(2):241-51. PubMed ID: 9343371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of p53 by the concerted actions of aziridine and quinone moieties of diaziquone.
    Ngo EO; Nutter LM; Sura T; Gutierrez PL
    Chem Res Toxicol; 1998 Apr; 11(4):360-8. PubMed ID: 9548807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of free radical formation by quinone antitumour agents in MCF-7 cells and the role of NAD(P)H (quinone-acceptor) oxidoreductase (DT-diaphorase).
    Fisher GR; Patterson LH; Gutierrez PL
    Chem Biol Interact; 1993 Sep; 88(2-3):137-53. PubMed ID: 8403076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships for DT-diaphorase reduction of hypoxic cell directed agents: indoloquinones and diaziridinyl benzoquinones.
    Bailey SM; Suggett N; Walton MI; Workman P
    Int J Radiat Oncol Biol Phys; 1992; 22(4):649-53. PubMed ID: 1544832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism(s) of bioreductive activation. The example of diaziquone (AZQ).
    Gutierrez PL
    Free Radic Biol Med; 1989; 6(4):405-45. PubMed ID: 2651223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration in DNA cross-linking and sequence selectivity of a series of aziridinylbenzoquinones after enzymatic reduction by DT-diaphorase.
    Lee CS; Hartley JA; Berardini MD; Butler J; Siegel D; Ross D; Gibson NW
    Biochemistry; 1992 Mar; 31(11):3019-25. PubMed ID: 1372518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between DT-diaphorase-mediated metabolism of a series of aziridinylbenzoquinones and DNA damage and cytotoxicity.
    Gibson NW; Hartley JA; Butler J; Siegel D; Ross D
    Mol Pharmacol; 1992 Sep; 42(3):531-6. PubMed ID: 1406604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of NAD(P)H: quinone reductase (EC 1.6.99.2, DT-diaphorase) in the reductive bioactivation of the novel indoloquinone antitumor agent EO9.
    Walton MI; Smith PJ; Workman P
    Cancer Commun; 1991 Jul; 3(7):199-206. PubMed ID: 1714284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of p21 mediated by reactive oxygen species formed during the metabolism of aziridinylbenzoquinones by HCT116 cells.
    Qiu X; Forman HJ; Schönthal AH; Cadenas E
    J Biol Chem; 1996 Dec; 271(50):31915-21. PubMed ID: 8943236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism for the reductive activation of diaziquone.
    Mossoba MM; Alizadeh M; Gutierrez PL
    J Pharm Sci; 1985 Dec; 74(12):1249-54. PubMed ID: 4087189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of DNA strand breakage and interstrand cross-linking by diaziridinylbenzoquinone (diaziquone) in isolated nuclei from human cells.
    Szmigiero L; Kohn KW
    Cancer Res; 1984 Oct; 44(10):4453-7. PubMed ID: 6467205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alkylation of DNA by the new anticancer agent 3,6-diaziridinyl-2,5-bis(carboethoxyamino)-1,4-benzoquinone (AZQ).
    King CL; Wong SK; Loo TL
    Eur J Cancer Clin Oncol; 1984 Feb; 20(2):261-4. PubMed ID: 6538490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.